Immunoglobulin Light-Chain Amyloidosis: Growing Recognition, New Approaches to ... Cancer Network Corticosteroids, alkylating agents, immunomodulatory drugs, and proteasome inhibitors all have shown activity in this disorder, and combinations are currently being explored in clinical trials. Despite advances in the past decade, 30% of patients still ... |
